Long-term remission in an aggressive Crooke cell adenoma of the pituitary, 18 months after discontinuation of treatment with temozolomide

被引：16

作者：

Asimakopoulou, Athina ^{[1
]}

Tzanela, Marinela ^{[1
]}

Koletti, Ageliki ^{[1
]}

Kontogeorgos, George ^{[2
]}

Tsagarakis, Stylianos ^{[1
]}

机构：

[1] Evangelismos Med Ctr, Dept Endocrinol, Ipsilantous 45-47, Athens 10676, Greece

[2] G Genimatas Hosp, Dept Pituitary Pathol, Athens, Greece

来源：

CLINICAL CASE REPORTS | 2014年 / 2卷 / 01期

关键词：

Crook's cell adenoma; Cushing's disease; temozolamide;

D O I：

10.1002/ccr3.39

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The clinical course of our patient, who sustained remission status for at least 18 months highlights the chance of long-term hormonal and tumor remission and demonstrates the efficacy and safety of discontinuation of temozolomide therapy. Prospective studies are required in order to define predictors of longterm remission of this promising therapeutic modality.

引用

页码：1 / 3

页数：3

共 5 条

[1] Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression [J].

Bush, Zachary M. ;

Longtine, Janina A. ;

Cunningham, Tracy ;

Schiff, David ;

Jane, John A., Jr. ;

Vance, Mary Lee ;

Thorner, Michael O. ;

Laws, Edward R., Jr. ;

Lopes, M. Beatriz S. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (11) :E280-E290

[2] DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors [J].

Hirohata, Toshio ;

Asano, Kenichiro ;

Ogawa, Yoshikazu ;

Takano, Shingo ;

Amano, Kosaku ;

Isozaki, Osamu ;

Iwai, Yoshiyasu ;

Sakata, Kiyohiko ;

Fukuhara, Noriaki ;

Nishioka, Hiroshi ;

Yamada, Shozo ;

Fujio, Shingo ;

Arita, Kazunori ;

Takano, Koji ;

Tominaga, Atsushi ;

Hizuka, Naomi ;

Ikeda, Hidetoshi ;

Osamura, R. Yoshiyuki ;

Tahara, Shigeyuki ;

Ishii, Yudo ;

Kawamata, Takakazu ;

Shimatsu, Akira ;

Teramoto, Akira ;

Matsuno, Akira .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (03) :1130-1136

[3] USE OF TEMOZOLOMIDE IN AGGRESSIVE PITUITARY TUMORS: CASE REPORT [J].

Mohammed, Safraz ;

Kovacs, Kalman ;

Mason, Warren ;

Smyth, Harley ;

Cusimano, Michael D. .

NEUROSURGERY, 2009, 64 (04) :773-774

[4] Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment [J].

Raverot, Gerald ;

Castinetti, Frederic ;

Jouanneau, Emmanuel ;

Morange, Isabelle ;

Figarella-Branger, Dominique ;

Dufour, Henry ;

Trouillas, Jacqueline ;

Brue, Thierry .

CLINICAL ENDOCRINOLOGY, 2012, 76 (06) :769-775

[5] Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience [J].

Raverot, Gerald ;

Sturm, Nathalie ;

de Fraipont, Florence ;

Muller, Marie ;

Salenave, Sylvie ;

Caron, Philippe ;

Chabre, Olivier ;

Chanson, Philippe ;

Cortet-Rudelli, Christine ;

Assaker, Richard ;

Dufour, Henry ;

Gaillard, Stephan ;

Francois, Patrick ;

Jouanneau, Emmanuel ;

Passagia, Jean-Guy ;

Bernier, Michele ;

Cornelius, Aurelie ;

Figarella-Branger, Dominique ;

Trouillas, Jacqueline ;

Borson-Chazot, Francoise ;

Brue, Thierry .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (10) :4592-4599

← 1 →